Active	Status	Sponsor type	Region	Phase	Filter
1 Active 9 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Haefeli, Walter E
NCT06435507: Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers	Completed	1	18	Europe	IM-250 (50 mg), IM-250 (100 mg), IM-250 (200 mg), IM-250 (400 mg)	Innovative Molecules GmbH	Herpes Simplex Virus	01/24	05/24